How to Finance a Rheumatology Practice Buy-In
A rheumatology practice buy-in lets an associate physician become a partner and share in the ownership and profits of the group. In rheumatology, that ownership may include not only the clinical practice but also infusion services, imaging and sometimes a separate entity that owns the building.
Because a buy-in can represent a significant investment, many physicians use financing to fund it. This article explains how buy-ins are often structured, how they may be valued and what lenders review. Ownership rules, partnership terms and tax treatment vary, and nothing here is legal, tax, billing or compliance advice.
What You May Be Buying Into
Before discussing price, clarify exactly what the buy-in includes. A rheumatology practice buy-in may cover:
- The professional practice: a share of the clinical entity and its profits
- Infusion and ancillary services: equity in the infusion program, ultrasound or bone density imaging
- Hard assets: a share of equipment, furniture and technology
- Accounts receivable and inventory: sometimes included, sometimes excluded
- Real estate: often held in a separate entity with its own buy-in terms
Each component may be valued and financed differently. Structures that involve ancillary ownership should be reviewed by healthcare counsel, since referral and ownership rules can be complex.
How Buy-In Price Is Often Determined
Groups use a variety of methods to set a buy-in price. Some rely on a formal valuation, while others use a formula in the partnership agreement. Common considerations include the value of hard assets, the group’s normalized earnings, the value of the infusion program and any goodwill.
Our article on rheumatology practice valuation explains the factors that typically drive value. An independent advisor or accountant can help an incoming partner understand whether the price is reasonable.
Questions to Ask Before You Commit
- What exactly does the buy-in include, and what is excluded?
- How will compensation change after you become a partner?
- How are infusion profits allocated among partners?
- What are your voting rights and decision-making authority?
- What happens if a partner leaves, retires or becomes disabled?
- Are there separate terms for the real estate entity?
Reviewing the partnership or operating agreement with counsel before signing is essential.
Ways to Pay for a Buy-In
Physicians may fund a rheumatology practice buy-in through:
- A practice loan: a bank loan to the incoming partner to pay the purchase price
- Salary reduction or deferred payments: the price is paid over time through adjusted compensation, as set by the group
- A combination: part financed by a lender and part paid over time
Using a loan lets the incoming partner pay the group at closing while spreading payments over time. Conventional practice loans are commonly considered for buy-ins, and in some cases SBA loans for rheumatology practices may be an option depending on eligibility, program rules and lender review. Every loan is subject to approval, and nothing here is a commitment to lend.
What Lenders Review for a Rheumatology Practice Buy-In
Lenders evaluating a buy-in loan typically look at both the incoming partner and the group:
- The physician’s training, credit history and personal finances
- The group’s tax returns and financial statements
- The draft partnership or operating agreement
- How the buy-in price was determined
- Expected partner compensation and distributions after the buy-in
- The stability of infusion revenue and payer mix
Because infusion revenue can be a large share of profit, lenders may ask how sensitive partner income is to changes in drug payment or biosimilar adoption.
Buying Into the Real Estate
If the partners own the building through a separate entity, the incoming partner may be offered a share. This can build long-term equity but adds another obligation. Some physicians buy into the practice first and the real estate later. Our article on the rheumatology office buy or lease decision covers how practice real estate is often evaluated.
Planning Your Personal Cash Flow
After the buy-in, your take-home pay will reflect partner distributions minus loan payments and any tax changes. Building a simple personal budget helps ensure the new obligation fits alongside student loans, a mortgage and family expenses. You can estimate loan payments with our conventional loan calculator for planning purposes only, and an accountant can help with the tax side.
Thinking Ahead to the Exit
A buy-in agreement should also address how partners eventually leave. Clear buyout terms protect both the incoming partner and the group. Our article on rheumatology partner buyout financing explains how groups often fund the purchase of a departing partner’s interest.
Timing the Buy-In
Many groups offer partnership after an associate period, which gives both sides time to evaluate fit. Using that time well can make the buy-in smoother.
- Ask for the partnership agreement and buy-in terms early
- Request the group’s financial statements before the offer is final
- Build personal savings and keep credit in good standing
- Speak with a lender before the buy-in date to understand options
Starting the financing conversation early can help you compare structures and avoid a rushed decision when the partnership offer arrives. It also gives you time to ask the group how infusion profits have changed over recent years and how the partners expect them to evolve.
Final Thoughts
A rheumatology practice buy-in can be a strong step toward long-term ownership, especially when it includes a share of infusion and imaging services. Understanding what you are buying, how the price was set and how financing fits your personal budget can help you make a confident decision.
US Medical Funding helps rheumatologists finance buy-ins and practice purchases. Learn more about our rheumatology practice acquisition financing.



